BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin R...
Becton, Dickinson and Company ,a leading global medical technology company announced it has received U.S. Food and Drug Administration (FDA) clearance for its new...
Becton, Dickinson and Company Receives FDA Clearance for New Syringe Designed for Humulin ...
BD (Becton, Dickinson and Company) a leading global medical technology company, today announced it has received U.S. FDA clearance for its new syringe for...
Cincinnati Childrens/UC Health Proton Therapy Center Opens with ProBeam System from Varian
Cincinnati Children's/UC Health Proton Therapy Center officially opened today equipped with the ProBeam® System from Varian Medical Systems . Housing two treatment rooms offering...
Quick Expands Global Healthcare Logistics Service Capabilities
Provides Cold Chain Transport and Chain of Custody for Personalized Medicine, From Research and Development, to Delivery to Each Patient. Immunotherapy drugs are one of...
Pathway Health Announce Strategic Partnership with Virtual Health
Pathway Health and Virtual Health, the leading provider of population health management technology for value-based care, have announced a new strategic partnership that will...
Novartis CDK4/6 inhibitor receives FDA approval for treatment for advanced breast cancer
Novartis announced that the US FDA has granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for the treatment of hormone receptor...
Siemens Zika Test Receives FDA Emergency Use Authorization
Siemens Healthcare Diagnostics Inc. Receives Emergency Use Authorization from FDA for its VERSANT® Zika RNA 1.0 Assay (kPCR) KitThe U.S. FDA has granted Siemens...
Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients
Next-Generation Recapturable Device is the First-of-its-Kind Approved in Europe to Treat Intermediate Risk Patients as an Alternative to Open-Heart SurgeryMedtronic plc announced CE (Conformité...
Kindred Healthcare and CHI Franciscan Health Announce Plans for Inpatient Rehabilitation Hospital
Kindred Healthcare, Inc. announced that it has signed a definitive agreement with CHI Franciscan Health to create a joint venture to construct and operate...
Janssen and Bristol-Myers Squibb Company in collaboration over immuno-oncology in lung cancer
Janssen Biotech, Inc announced it has entered into a clinical study collaboration agreement with Bristol-Myers Squibb Company to evaluate the combination of two immuno-oncology...
